Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Sunday, November 8, 2026

Back to the front page

Perimeter Group: 3Q26 Business Recap

Perimeter Group posted 24% revenue growth to $390 million as fire-safety contracts and acquisitions lifted results, while it brings PDI supply in-house after Flexsys disruptions.

PRM $4.8B
Speedwell Memos 1 click

From X

@aleabitoreddit

Serenity on X

Everyone’s a long term investor for 2027, 2028, or 2029 onward Until their portfolio experiences volatility months in. I still think: - $RKLB could end up the next $SPCX - $NBIS has the potential to be the next hyperscaler - $SIVE has moonshot potential to be the next $LITE - 1-3x P/E memory companies and $AXTI substrate bottlenecks are more durable than markets think And that it’s stupid to sell single digit fwd P/E AI companies or promising longs. And rotate that into 5% growth towel resellers at 47x P/E. Or 180x cyber companies, just because they’re going up. I’ve seen $AMD go from the $3 valley of doom to $400 as people thought it could be the next $INTC / $NVDA. And been through the Bitcoin $1000 -> $18,000 -> $3000 -> $100,000 cycle. Not advice on how to position or trade, but anyone on extreme leverage during those times got wiped out. While the underlying assets sharply recovered later. I do think AI, Space, and Physical AI are the future. So, I’m remaining long, and using this time to maximize exposure to the winners
@aleabitoreddit 2 clicks

Serenity on X

$AAOI earnings: - $1B-$1.5B LTA disclosed with a hyperscaler customer - 2nd LTA coming soon, worth 5x+ more (implying $5B-$7.5B), in its final stages. This LTA explicitly includes lasers, very material for AOI that they're moving to supplying merchant lasers. - "The demand is exceptional, unprecedented. I do not know what kind of superlatives to use to describe the amount of demand that we are seeing out there in the industry" Yeah this commentary doesn't sound like any optical demand would slowed down if it's "exceptional + unprecedented" - Rejected hyperscaler slowdowns from political changes with little effect. - AOI Can only meet 80% of demand, in case there's a kind of reduction, the demand would be bigger than AOI future capacity - Moving toward other financing methods than ATMs (thank god), US bank loans similar to what $NBIS is doing, I'd argue is positive, given FCF coming in later. - Delay in meeting capacity projections into H1 2027. $471m/month targets pushed back into H2 2027, due to electrical procurement and construction logistics, which existed before Texas governor changed. This part is negative part of the earnings call. To qualify this, I don't quite think hyperscalers would sign a $5-$7.5B LTA if they didn't think AOI couldn't deliver. - Near term Q4 guidance cut was DSP availability. AOI revised near term projections down slightly to $385M and $420M in revenue. Said DSP supply would ease early 2027 and that they're qualifying more suppliers. - Gave hiked H2 2027 capacity projections from their expansion, near term revision downward. - 4 to 5 ongoing UHP laser eval/quals for CPO UHP laser segment alone would far outweigh their $3.8B MC, especially if you're executing on multi billion dollar contracts with 60%+ gross margin laseres. TLDR: - Long term visibility improved a lot, with est. $6-$9B cumulative LTA contracts coming soon. - Shift toward supplying CPO lasers merchant is fundamentally material vs. just transceivers, and what I wanted to hear - Capacity guidance hiked into H2 2027, near term delays from electrical/DSP related procurement + installation. I still think we're reached peak fear levels, but wouldn't dismiss disappointing short term procurement delays + Q4 DSP bottlenecks. AOI likely signing an additional +$5-$7.5B in likely hyperscaler LTAs and entering merchant UHP CPO market dominanted by $LITE + $COHR. Factored in with the valuation drop has made medium-long term opportunities very compelling.

Investor Letters

All letters

Problems at Twist Bioscience (TWST)

Twist Bioscience’s $200 rebound followed an Anthropic-linked short squeeze, yet its DNA and protein services face broad competition while…

TWST $8B
Hunterbrook 4 clicks

VSH Earnings Review

Vishay reported record Q3 revenue of $979 million, up 24%, and guided Q4 to about $990 million as rising backlog and margins contrast with…

VSH $3.6B
Cestrian Capital Research 3 clicks
AAP · long

Advance Auto Parts INC

Advance Auto Parts, AAP, is presented as a long idea following prior write-ups at $48.81 per share in January 2025.

AAP $2.9B
Value Investors Club 1 click

New Ideas From The Road

Aurelion Research increased healthcare exposure and sees opportunities in banking and defense, alongside research on Alcoa, Nike, ONON and…

MDA $4.2B
Aurelion Research 4 clicks

Site Centers (NYSE:SITC)

Site Centers' $3 per-share return-of-capital distribution and December delisting leave a discounted liquidation stub, with two properties…

CURB $3.6B
Real Assets, Real Value 5 clicks

Stevanato down 30%. Yikes.

Stevanato fell 30% after forecasting low-single-digit 2027 growth as lower Nexa syringe volumes from a GLP-1 customer offset solid Q3…

STVN $3.6B
Best Anchor Stocks 3 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 74 of 279

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

359 firms

Sectors

Ordered by how often our editor reaches for them.